A team of researchers led by Paolo Fiorina, M.D., Ph.D. of Boston Children’s Hospital – Harvard Medical School has found that abatacept may help prevent kidney disease caused by diabetes. The autoimmune drug, which works by targeting a receptor called B7-1, is prescribed for rheumatoid arthritis and is also being used in clinical trials for … Continue reading Abatacept May Help Prevent Kidney Disease Caused by Diabetes
Repurposed Drug as First Targeted Treatment for FSGS
Researchers from Massachusetts General Hospital have identified abatacept (also known as Orencia), a drug for rheumatoid arthritis, as a potential treatment for FSGS. All five patients in the study showed signs of improvement after taking the drug. Four of the patients in danger of losing their transplanted kidneys were treated successfully and a fifth patient … Continue reading Repurposed Drug as First Targeted Treatment for FSGS